Bio Vitos Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Bio Vitos Pharma
Access all reports
Bio Vitos Pharma AB, previously known as Hemcheck Sweden AB, is a medical technology company based in Sweden. The company specializes in developing and commercializing solutions for the detection of hemolysis in blood samples. Their primary product is a combination of disposable tests and readers designed to quickly identify hemolyzed blood samples in vacuum tubes and blood gas syringes. This technology aims to enhance patient safety, streamline healthcare processes, and reduce costs by ensuring accurate blood sample analysis. Bio Vitos Pharma serves the healthcare sector, particularly targeting emergency departments in Europe and the United States. The company is headquartered in Solna, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
Prada: The Story of an Icon
Prada's journey from a small Milan boutique to a global luxury empire, led by Miuccia's innovation and creativity.
5 Dec 2024
Hims & Hers: Bridging Gaps in Telehealth
Hims & Hers was founded in 2016 by Andrew Dudum and has grown into a ~$4 billion company in the telehealth industry in less than a decade.
5 Dec 2024
Andrew Dudum: Founder and CEO of Hims & Hers
Andrew Dudum is the founder and CEO of Hims & Hers, an innovative telehealth company focused on bridging the gap between consumers and healthcare.
4 Dec 2024
Ticker symbol
BIOVIT
Country
πΈπͺ Sweden